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Abstract
Purpose Given increasing interest in using the capability approach for health economic evaluations and a growing literature, 
this paper aims to synthesise current information about the characteristics of capability instruments and their application in 
health economic evaluations.
Methods A systematic literature review was conducted to assess studies that contained information on the development, 
psychometric properties and valuation of capability instruments, or their application in economic evaluations.
Results The review identified 98 studies and 14 instruments for inclusion. There is some evidence on the psychometric prop-
erties of most instruments. Most papers found moderate-to-high correlation between health and capability measures, ranging 
between 0.41 and 0.64. ASCOT, ICECAP-A, -O and -SCM instruments have published valuation sets, most frequently devel-
oped using best–worst scaling. Thirteen instruments were originally developed in English and one in Portuguese; however, 
some translations to other languages are available. Ten economic evaluations using capability instruments were identified. 
The presentation of results show a lack of consensus regarding the most appropriate way to use capability instruments in 
economic evaluations with discussion about capability-adjusted life years (CALYs), years of capability equivalence and the 
trade-off between maximisation of capability versus sufficient capability.
Conclusion There has been increasing interest in applying the capability-based approach in health economic evaluations, but 
methodological and conceptual issues remain. There is still a need for direct comparison of the different capability instru-
ments and for clear guidance on when and how they should be used in economic evaluations.
Keywords Capability approach · Patient reported outcome measures · Outcome · Validation · Preference weighting · 
Economic evaluation
Background
Economic evaluations assess whether an intervention pro-
vides value for money through the comparative analysis of 
alternative courses of action in terms of both costs and con-
sequences [1]. The assessment of consequences in economic 
evaluation requires information about their identification 
(what), measurement (how much) and valuation (how valu-
able) [2]. Standard methods of health economic evaluations 
identify outcomes based on a rather narrow definition of 
health that aims to express outcomes in Quality-Adjusted 
Life Years (QALYs). However, there are many interven-
tions, particularly in the areas of mental health, end-of-life 
care, public health and social care, where the impacts of 
interventions go beyond this narrow view of health. The 
contemporary literature (e.g. [3–6]) recognises the need to 
move away from the standard methods for assessing effects 
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of interventions and toward incorporating outcomes beyond 
the QALY framework, when producing an economic evalu-
ation which feeds into decision making about resource allo-
cation in health-related interventions. The most promising 
approach to address this issue is the application of Sen’s 
capability framework, which was introduced by Sen [7] in 
the early 1980s as an alternative to standard utilitarian wel-
fare economics. The core focus of the capability approach is 
on what individuals are able to be and do in their lives (i.e. 
capable of). The application of the capability approach in 
health economics has gained popularity because it poten-
tially provides a richer evaluative space for the evaluation 
of interventions [8].
There has been increasing interest in developing instru-
ments for using the capability approach in the measurement 
and valuation of outcomes for health economic evaluations. 
Capability instruments have been in the public domain for 
over a decade and publications have started to shift from 
methodological issues towards use of the measures within 
economic evaluations. Some decision-making institutions 
currently recommend the inclusion of capability measures in 
economic evaluations in certain contexts. The Zorginstituut 
in the Netherlands [9] recommends the inclusion of ICEpop 
CAPability measure for Older people (ICECAP-O) along-
side the EuroQol instrument (EQ-5D) for the evaluation of 
interventions in long-term care, where the relevant outcomes 
extend beyond health. The most recent methods guideline 
[10] of the National Institute for Health and Care Excel-
lence (NICE) acknowledges that the intended outcomes of 
interventions go beyond changes in health status for some 
decision problems; hence, ‘broader, preference weighted 
measures of outcomes, based on specific instruments, may 
be more appropriate…’ and ‘the economic analysis may 
also consider effects in terms of capability and well-being’ 
(p. 137). The manual specifically recommends the Adult 
Social Care Outcomes Toolkit (ASCOT) and ICECAP-O 
instruments.
However, the choice between instruments and their 
practical application in particular contexts lack a system-
atic approach. For instance, the ICECAP-O recommended 
by NICE is targeted at a subgroup of the population (older 
adults), whilst the ASCOT was specifically developed for 
the assessment of social care interventions. A recent review 
of the literature examined current trends in the application 
of ICECAP-O [11]. The authors found that the ICECAP-O 
has mainly been included as a secondary economic measure 
and the reporting of results is brief with minimal detail and 
often no discussion or interpretation. An overview of the 
psychometric properties of all potential capabilities instru-
ments and their usefulness for economic evaluations would 
contribute to providing a clear guidance. This could later be 
used as a reference point for future comparative analysis of 
policies or interventions. Hence, the main aim of this paper 
is to synthesise the current evidence about the application of 
capability instruments in health economic evaluations. This 
translates into the following objectives: (i) to summarise 
information about the development, psychometric properties 
and preference valuation of relevant capability instruments; 
(ii) to compare the identified capability instruments in terms 
of their psychometric properties and up-to-date application 
in health economic evaluations; (iii) to identify applied 
evaluations that have used the capability-based approach in 
health economic evaluations and (iv) to pinpoint the chal-
lenges and considerations in the application of the capa-
bility approach in economic evaluations of health-related 
interventions.
Methods
Identification of relevant studies
The identification of papers was based on two main 
approaches: a traditional systematic literature search and a 
comprehensive pearl growing method [12]. The grey litera-
ture search in Google Advance either generated an unman-
ageable number of hits due to the term “capability” being 
used across a number of disciplines with varying meanings, 
as well as having generic lay use and interpretation of the 
term; or there was no addition to the search of other data-
bases when more precise terms were used. As the devel-
opment and validation of the capability approach in health 
economics currently appears to be concentrated among a 
limited group of researchers, as an additional step, websites 
dedicated to the instruments identified through the system-
atic search were specifically targeted and reviewed for rel-
evant information.
Systematic literature search
Firstly, we conducted a systematic literature search. Search 
terms combined expressions for economic evaluation and 
frequently used terms for the capability approach, including 
synonyms and names of instruments most well-known in 
the area of health economics. Search terms are presented in 
Appendix 1. The selection of databases was based on similar 
reviews of health measures (PROMs) [6, 13] in the area and 
included Embase, Medline, Web of Science, Psychinfo and 
Scopus. The literature search was conducted on 1 February 
2019 and the review was limited to the last 20 years when 
the first publications in this topic area appeared [14]. Rel-
evant systematic literature reviews were searched for further 
references and their findings were kept for comparison and 
discussion.
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Comprehensive pearl growing method
The term ‘capability’ produces very broad ranging results 
when used as a search term due to its wide range of mean-
ings, including lay meanings. The so-called comprehensive 
pearl growing method [12] is a technique used to ensure all 
relevant articles are included, particularly in case of issues 
with vocabulary in a search strategy. This method is particu-
larly useful in interdisciplinary research and where recent 
developments are expected in the literature. The process of 
pearl growing commences with the identification of ‘key 
pearls’ (i.e. key studies), that can be identified from within 
the literature as being compatible with the aim of the review 
[12]. Once the key pearls have been identified, these are used 
to generate the ‘first wave of pearls’, that is, papers that have 
cited the key pearls within their reference list. It has been 
used successfully in a different type of review in the context 
of capabilities [13]. This second approach was implemented 
to validate the strategy applied during the systematic search 
and to identify potential further papers.
Two waves of the pearl growing method were conducted: 
one focusing on the development of instruments and a sec-
ond wave related to the application of the instruments. A 
third wave was deemed unnecessary because the identi-
fied last generation of seminal papers were published only 
recently and have not been cited yet. The results are pre-
sented in Table 1. The first wave used for citation searching 
were the developmental studies of the four most commonly 
used and reported capability instruments: ASCOT, ICE-
CAP-O, its version for adults (ICECAP-A) and the Oxford 
CAPabilities questionnaire-Mental Health (OxCAP-MH). 
The second wave relied on the three main papers from the 
last 5 years (but already with some relevant citations) that 
aimed to identify recent developments and up-to-date knowl-
edge in the application of the capability approach in health 
economic evaluations. The number of citations was retrieved 
from Scopus on 14 March 2019.
Study selection
Titles and abstracts were sifted by two researchers (TL and 
AL) and studies were included for further assessment if they 
met the following inclusion criteria: (1) Full paper available 
in English or German languages. (2) Scope of study is the 
area of health or health-related interventions, including any 
interventions specifically targeting the promotion of health 
and prevention and treatment of ill-health irrespective of 
the sector where these were implemented. Hence, our study 
also included potentially relevant studies from the social care 
and public health sectors. (3) Focus of research is the evalu-
ation or assessment of the outcomes of interventions using 
the capability approach. (4) Paper includes information on 
the use (or recommended use) of the capability approach in 
economic evaluations. (5) Paper is an applied evaluation 
OR focuses on the development, psychometric validation 
(or comparison to other tools) or preference valuation of 
instruments.
The full paper was retrieved if a study met the inclusion 
criteria based on its title and abstract. Consequently, full 
papers were assessed by two researchers (TH and AL) for 
inclusion based on their contribution to at least one of the 
aims of this literature review and subsequently allocated 
to the categories of either (i) applied evaluations (using a 
capability instrument in a completed economic evaluation) 
or (ii, iii, iv, v) methods papers. Methods papers were fur-
ther categorised based on their relevance to the identifica-
tion, measurement and valuation of outcomes, as well as the 
practical application of tools and theoretical contributions. 
Papers were grouped into categories of (ii) instrument devel-
opment, (iii) psychometric validation or quantitative com-
parison of instruments, (iv) preference valuation of instru-
ments and (v) methods for incorporation of the capability 
approach in economic evaluations. The latter one includes 
potential fields of application, approaches to use the results, 
incorporation of the results into a potential framework, for 
instance, Capability-Adjusted Life Years (CALYs), years 
of full capability or years of sufficient capability equiva-
lence, etc. Some of the studies with significant theoretical 
Table 1  Key pearls for the two waves of the comprehensive pearl growing method
Wave Study Number of cita-
tions
Short description
Wave 1 [52] 92 Development of the ASCOT
[53] 146 Development of the ICECAP-A
[54] 158 Development of the ICECAP-O
[39] 66 Development of the OxCAP-MH
Wave 2 [48] 27 Description of new methods to conduct economic evaluations using the capability approach
[55] 13 Presents the opportunities and challenges of the capability approach in health economics
[49] 4 Critical review of relevant questionnaires to measure and value capability
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contributions to the application of the capability approach 
in health economic evaluations which did not fit the above 
criteria were noted for discussion.
No specific quality assessment was applied, all studies 
which provided information on either the psychometric 
properties or use of capabilities instruments in economic 
evaluations were included. The instruments were assessed 
based on their psychometric properties according to the 
COSMIN checklist [15], feasibility [16], potential for trans-
ferability and evidence regarding valuation.
Data extraction and analysis
Separate data extraction forms were created for empirical 
and psychometric evaluation (and other methods) studies. 
The search for information on valuation included any kind of 
preference-based valuation of instruments (or their dimen-
sions/domains) and the existence of value sets. Further infor-
mation on data extraction is presented in Appendix 2.
Trends in the literature were analysed based on the 
number of different types of studies published each year. 
The information elicited from the studies was structured 
according to the capability instrument in question. Infor-
mation about economic evaluations, and the psychometric 
properties and correlation coefficients from studies compar-
ing instruments are presented in review tables. Due to the 
variability of methods used in the validation and comparison 
studies, only narrative synthesis, including tabulation and 
frequency analyses, was conducted as no statistical pooling 
was possible. The information gathered was synthesised in 
a qualitative rather than quantitative manner by TH.
Results
Search results
The literature search identified 98 studies for inclusion 
(Appendix 4 provides a complete list). The pearl growing 
method identified 29 citations beyond those captured by the 
systematic search strategy. However, none of the additional 
references met the inclusion criteria, and the papers included 
in this review were actually all picked up by the systematic 
search. An overview of the literature search based on the 
PRISMA statement is presented in Fig. 1.
The increasing number of relevant publications in recent 
years is a clear trend (shown in Fig. 2). A further trend also 
appears to be a shift from developmental studies towards the 
Fig. 1  PRISMA chart
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validation of capability instruments and their use in empiri-
cal studies.
Instruments to assess capability
Development of instruments
The literature review identified 14 capability instruments. 
Table 2 shows the heterogeneity of the capability instru-
ments in terms of development methods, disease areas, types 
of interventions, population groups and the questionnaire 
structure.
Availability of evidence on the characteristics of capability 
instruments
As Table 3 demonstrates, there is at least some evidence 
about the psychometric properties of most instruments.
The most recently developed instruments, unsurprisingly, 
have less information available about their reliability, valid-
ity and responsiveness; an exception is OCAP-18 which was 
among the first capability instruments to be developed, but 
for which there is no further psychometric evidence availa-
ble. The main difference across different groups of capability 
instruments is whether valuations that reflect the preferences 
of patients or the general public are available. The ASCOT 
and most ICECAP instruments have reported valuation stud-
ies and are therefore considered to possess evidence regard-
ing their ability to reflect values of informants, whilst this is 
currently missing, for instance, for OxCAP-MH.
Different language versions of instruments
Apart from ACQ‐CMH‐104, all instruments were originally 
developed in English. The ASCOT, ICECAP-A, ICECAP-O 
and OxCAP-MH instruments have been translated to fur-
ther languages, and these new versions have been validated 
(Table 4).
Validation of capability instruments
Reliability The test–retest reliability of most instruments 
have been successfully assessed in some groups of popula-
tion, e.g. ACQ‐CMH‐104 [56]; ASCOT [72]; ICECAP-A 
[77]; ICECAP-O [86]; OxCAP-MH [19].
Validity There were 25 studies among the included papers 
that used Pearson’s or Spearman rank correlation coeffi-
cients to quantitatively assess the validity of all language 
versions of the capability instruments and/or compare it to 
other instruments. Quantitative evidence was provided on 
the validity of six capability instruments, including ACQ‐
CMH‐104, ASCOT, ICECAP-A, ICECAP-O, OxCAP-MH 
and Women’s Capabilities Index. Table 5 (and Appendix 5) 
summarise the correlations.
There is variation between studies in the correlation 
measures used, the instruments compared, the characteristics 
of the population, number of informants, testing of hypoth-
eses generated regarding likely associations between the 
data and testing across known groups for discriminant and 
convergent validity. Hence, it is difficult to provide general 
statements about the comparison of capability instruments 
with other PROMs, or to conduct statistical pooling of the 
Fig. 2  Annual changes in the number and type of publications related to using the capability approach in the economic evaluation of health-
related interventions. Year 2019 not included in this figure because data were not available for the full year. Instruments to assess capability
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results. High correlation estimates (above 0.8) were found 
between capability instruments: ASCOT/ICECAP-O [49] 
and ICECAP-A/AQoL-8D [20].
The examined studies provided very diverse estimates 
for the correlations between Health-related Quality of Life 
(HRQoL) and the different capability instruments. Most 
studies compared the ASCOT, ICECAP-A and ICECAP-O 
instruments with either disease-specific or generic HRQoL 
instruments. A wide range of disease-specific instruments 
were applied across studies, mainly being used when 
informants consisted of patients and social care recipients. 
EQ-5D-3L/-5L was used in 92% (n = 23) of the included 
validation and comparison studies as a HRQoL measure. 
In most cases, the 5L version of the EQ-5D instruments 
provided higher correlation coefficients compared to the 3L 
version. The higher correlation with capability instruments 
could be explained by lower ceiling effects and higher sen-
sitivity to minor changes in the 5L version compared to the 
3L version.
There seem to be a consensus in the literature that the 
capability approach provides complementary information to 
HRQoL measures. However, capability instruments could 
also be perceived as enhanced rather than complementary 
to the narrow interpretation of well-being/quality of life 
when focusing only on HRQoL. Most studies [25–27] found 
that the ICECAP and EQ-5D instruments provide comple-
mentary information, and a mapping is not recommended 
between them. Engel et al. [24] found that the ICECAP-A 
provides evidence above that gathered from most commonly 
used preference-based HRQoL instruments. Similar findings 
were reported for other capability instruments. Forder and 
Caiels [68] found that ASCOT has greater validity in meas-
uring the effects of social care services than EQ-5D. Van 
Leeuwen et al. [28] investigated the validity of ICECAP-O 
and ASCOT among Dutch older adults. Although it could 
be attributable to cultural transferability issues, they found 
that respondents did not feel that these instruments give a 
comprehensive picture of their HRQoL because they did not 
find all domains of the instruments relevant, whilst other 
important domains were not covered, particularly concerns 
or delight about the well-being of family members. HRQoL 
instruments capture an important part of broader well-being, 
and some studies [22, 23] established strong and positive 
association between capability and HRQoL instruments, 
which questions whether they focus on complementary 
constructs. Evidence suggests that some capability instru-
ments could rather be interpreted as an enhancement of the 
HRQoL concept, for instance, an exploratory factor analysis 
[17] found that all EQ-5D-5L items and seven OxCAP-MH 
items loaded on one factor and nine remaining OxCAP-MH 
items loaded on a separate factor.
It is questionable whether the issues discussed above 
relate to all HRQoL measures or only the EQ-5D Utility Ta
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instrument. Lower correlation between the OxCAP-MH and 
EQ-5D Utility scores was observed in the Vergunst et al. 
[19] study than between OxCAP-MH and EQ-5D-VAS. This 
could be explained by the fact that the latter reflects the 
patient’s overall judgement about their health status rather 
than focusing only five dimensions of their health, which is 
arguably more in line with the underlying broader well-being 
concept and the used non-preference-based index score of 
the OxCAP-MH instrument.
Interpretability In terms of ease of understanding, Bailey 
et  al. [29] investigated the appropriateness of ICECAP-
SCM to measure QoL and found that the capability instru-
ment appeared more meaningful, easier to complete and 
had fewer errors among patients and close persons, com-
pared to EQ-5D-5L. However, these results did not apply to 
healthcare professionals who preferred the EQ-5D-5L over 
ICECAP-SCM when measuring clinician-rated health states 
because it focused on observable attributes. Similar studies 
have also demonstrated the feasibility of use of other ICE-
CAP measures [81, 90]. Malley et al. [70] and Towers et al. 
[67] demonstrated the feasibility of using ASCOT among 
older people and care home residents; however, the study 
also highlighted the need for proxy respondents in some sit-
uations. This later led to the development of a proxy version 
of the ASCOT, which demonstrated good feasibility [58]. 
Davis et al. [30] reported that the level of agreement between 
patient and proxy for the EQ-5D-3L was significantly bet-
ter than the level of agreement observed for the ICECAP-O 
in case of patients with vascular cognitive impairment. The 
authors conclude that due to its complexity, the ICECAP-O 
may have limited clinical, research and policy-related utility 
among individuals with mild cognitive impairment. How-
ever, these results need to be interpreted carefully due to the 
differing number of levels and the greater ability of prox-
ies to observe the dimensions in EQ-5D. Although it could 
be explained by translational issues, van Leeuwen [28] who 
also reported difficulties with understanding the ASCOT 
and ICECAP-O in a study assessing a small number (n = 10) 
of Dutch, community-dwelling frail older adults. Simon 
Table 3  Availability of evidence on the characteristics of capability instruments for health economic evaluations
Instrument Reliability Validity Responsiveness Interpretability/Feasibility Valuation
ACQ‐CMH‐104 [66] [66] Unknown Unknown Unknown
ASCOT [67] [21, 68, 69, 70, 71, 72, 73, 74] [71] [75] [52]
ASCOT easy read Unknown Unknown Unknown [57] Unknown
ASCOT-proxy Unknown Unknown Unknown [58] Unknown
ASCOT-carer [76] [76] Unknown Unknown Unknown
CAF Unknown Unknown Unknown [60] Unknown
ICECAP-A [77] [20, 23, 24, 27,  33, 34, 38,  78, 79, 
80]
[23, 32, 33, 34, 37, 81] [82, 83, 84] [85]
ICECAP-CPM Unknown Unknown Unknown Unknown Unknown
ICECAP-O [30, 86, 87] [18, 21,  22, 25, 26, 40, 74, 87, 88, 89, 
90, 91, 92, 93, 94, 95, 96]
[26, 31, 35, 36, 95, 97] [25, 26, 30, 40, 89, 91, 98, 99] [88]
ICECAP-SCM Unknown Unknown Unknown [29, 83] [100, 101]
low-income Q Unknown [102] Unknown Unknown Unknown
pain Q Unknown Unknown Unknown Unknown Unknown
OCAP-18 Unknown Unknown Unknown Unknown Unknown
OxCAP-MH [17, 19, 103] [17, 19, 103] [17] [39] Unknown
Table 4  Availability of different language versions of capability 
instruments
a Information on unpublished translations of instruments stem from 
the dedicated websites of the instruments
Instrument Availability of language versions beside  Englisha
ACQ‐CMH‐104 Only available in Portuguese language
ASCOT Japanese [105]; Dutch [106]
ASCOT easy read None identified
ASCOT-proxy None identified
ASCOT-carer None identified
CAF None identified
ICECAP-A Chinese [107], Danish (unpublished), Dutch 
(unpublished), German [107], Italian 
(unpublished), Persian (unpublished), Welsh 
(unpublished)
ICECAP-CPM none identified
ICECAP-O Chinese (unpublished), Dutch [92], French 
(unpublished), German [18], Spanish [87], 
Swedish [86], Welsh (unpublished); Italian, 
Norwegian and Portuguese [109]
ICECAP-SCM None identified
low-income Q None identified
pain Q None identified
OCAP-18 None identified
OxCAP-MH German [103]
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Table 5  Construct validity of capability instruments for health economic evaluations
Capabilities 
instrument
Compared with… (full names in 
Appendix 5)
Value of cor-
relation*
Population (country in Appendix 5) Number of 
informants
References
ACQ‐CMH‐104 RAS 0.46* Psychiatric patients 92 [66]
WHOQOL‐Bref 0.60* Psychiatric patients 129 [66]
ASCOT Barthel Index 0.45 Older social care users 205 [21]
Cantril’s Ladder 0.66 Older social care users 205 [21]
CASP-12 0.58 Older home care residents 301 [52]
EQ-5D-3L 0.41 Older home care residents 301 [52]
EQ-5D-3L 0.40 Older home care residents 301 [70]
EQ-5D-3L 0.47 Older home care residents 224 [68]
EQ-5D-3L 0.41* Frail older adults living at home 190 [74]
EQ-5D-3L 0.37 Older social care users 748 [72]
EQ-5D-5L 0.63 Older social care users 205 [21]
EQ-5D-5L 0.24 Older adults in a day rehabilitation facility 22 [71]
EQ-5D-VAS 0.64 Older social care users 205 [21]
GDS-15 − 0.69 Older social care users 205 [21]
GHQ-12 − 0.58 Older home care residents 301 [52]
ICECAP-A 0.62 Older social care users 748 [72]
ICECAP-O 0.81 Older social care users 205 [21]
ICECAP-O 0.41* Frail older adults living at home 190 [74]
ICECAP-O 0.67 Older social care users 748 [72]
OPQOL-13 0.76 Older social care users 205 [21]
OPQOL-brief 0.38 Older adults in a day rehabilitation facility 22 [71]
OPQoL-Brief 0.58 Older social care users 87 [69]
SWLS 0.74 Older social care users 205 [21]
ASCOT-Carer CES 0.58 Social care recipients 376 [76]
CSI − 0.59 Social care recipients 384 [76]
EQ-5D-3L 0.34 Social care recipients 382 [76]
QoL 0.62 Social care recipients 384 [76]
ICECAP-A 15D 0.50* Healthy general public and patients from 8 
disease areas
6756 [24]
AQoL-8D 0.31* Healthy general public and patients from 8 
disease areas
6756 [24]
AQoL-8D 0.80 Healthy general public and patients with 7 
chronic conditions
8022 [20]
EQ-5D-3L 0.53 Women with lower urinary tract infection 478 [23]
EQ-5D-3L 0.49 Knee pain patients in primary care 500 [27]
EQ-5D-5L 0.62* Healthy general public and patients with 7 
chronic conditions
1212 [108]
EQ-5D-5L 0.49* Healthy general public and patients from 8 
disease areas
6756 [24]
EQ-5D-5L 0.60 Healthy general public and patients with 7 
chronic conditions
8022 [20]
HUI-3 0.32* Healthy general public and patients from 8 
disease areas
6756 [24]
LDQ − 0.48 Opiate substitution recipients 83 [34]
SF-6D 0.64* Healthy general public and patients with 7 
chronic conditions
1212 [108]
SF-6D 0.47* Healthy general public and patients from 8 
disease areas
6756 [24]
SSQ 0.43 Opiate substitution recipients 83 [34]
SWLS 0.66* Healthy general public and patients with 7 
chronic conditions
1212 [108]
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Values in italic are Pearson’s coefficients, values in standard writing are Spearman rank correlations. A * behind the value means that the study 
used a non-English version of the capability instrument
Table 5  (continued)
Capabilities 
instrument
Compared with… (full names in 
Appendix 5)
Value of cor-
relation*
Population (country in Appendix 5) Number of 
informants
References
ICECAP-O ADRQL 0.53* Nursing home residents with dementia 95 [18]
Barthel Index 0.49 Older social care users 209 [21]
Barthel Index 0.72* Nursing home residents with dementia 95 [18]
Cantril’s Ladder 0.74 Older social care users 213 [21]
CTM-3 0.23 Patients from outpatient day rehabilitation unit 82 [22]
EQ-5D-3L 0.34 Older people with hip fracture 113 [95]
EQ-5D-3L 0.69* Nursing home residents with dementia 95 [18]
EQ-5D-3L 0.53 Older people after hip fracture surgery 87 [93]
EQ-5D-3L 0.44 Patients from outpatient day rehabilitation unit 80 [22]
EQ-5D-3L 0.47 Patients visiting the clinic 215 [25]
EQ-5D-3L 0.63 Frail older adults living at home 190 [74]
EQ-5D-5L 0.68 Older social care users 207 [21]
EQ-5D-5L 0.63 General population aged 70 or older 516 [90]
EQ-5D-VAS 0.66 Older social care users 208 [21]
GDS-15 − 0.73 Older social care users 210 [21]
OHS 0.38 Older people with hip fracture 113 [95]
OPQOL-13 0.80 Older social care users 211 [21]
SWLS 0.82 Older social care users 212 [21]
ICECAP-O fam-
ily version
EQ-5D family version 0.57* Nursing professionals of psycho-geriatric elderly 96 [92]
EQ-VAS family version 0.43* Family members of psycho-geriatric elderly 68 [92]
ICECAP-O nurs-
ing version
EQ-5D nursing version 0.48* Nursing professionals of psycho-geriatric elderly 96 [92]
EQ-VAS nursing version 0.55* Family members of psycho-geriatric elderly 68 [92]
OxCAP-MH BPRS − 0.41 Patients with psychosis 172 [19]
BSI-18 − 0.67* Patients in socio-psychiatric services 162 [17]
EQ-5D VAS 0.58* Patients in socio-psychiatric services 161 [17]
EQ-5D-3L 0.45 Patients with psychosis 172 [19]
EQ-5D-5L 0.66* Patients in socio-psychiatric services 160 [17]
EQ-5D-VAS 0.52 Patients with psychosis 172 [19]
GAF 0.24 Patients with psychosis 172 [19]
GAF 0.35* Patients in socio-psychiatric services 168 [17]
Mini-ICF-APP − 0.47* Patients in socio-psychiatric services 167 [17]
SIX 0.12 Patients with psychosis 172 [19]
WHOQOL-Bref Environment 0.69* Patients in socio-psychiatric services 166 [17]
WHOQOL-BREF Physical 
health
0.69* Patients in socio-psychiatric services 163 [17]
WHOQOL-Bref Psychological 0.75* Patients in socio-psychiatric services 164 [17]
WHOQOL-Bref Social relation-
ships
0.50 Patients in socio-psychiatric services 165 [17]
Women’s Capa-
bilities Index
WHOQOL-Bref 0.62* Women from Malawi 20 [64]
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et  al. [39] explored the feasibility of OxCAP-MH among 
severely ill mental health service users. Patients provided 
positive feedback and felt that the questions allowed them 
to express their views and experience on topics they consid-
ered important but which were often left out of clinical or 
research interviews [39].
Responsiveness The sensitivity of the capability instru-
ments to measure changes is generally reported to be higher 
than in case of HRQoL measures [6, 17, 31–34]. However, 
some authors found capability instruments to be less respon-
sive than HRQoL measures. Davis et al. [35] and Couzner 
et al. [36] reported that the difference in values between the 
patient and general population groups was found to be far 
more pronounced for the EQ-5D-3L than for the ICECAP-
O. There is a consensus in the literature that changes related 
to the broader meaning of health are better captured by the 
capability instruments than by EQ-5D [37–39]. Coast et al. 
[40] found strong evidence of association of general health 
with all capability attributes except for the attachment 
domain of ICECAP-A. Laszewska et al. [17] found that the 
OxCAP-MH may be seen as enhanced rather than comple-
mentary in its concept, when compared to EQ-5D-5L.
Valuation of instruments
From the reviewed 14 capability instruments, only four have 
a published valuation set. These used the best–worst scaling 
method, most often relying on the MaxDiff model. Inform-
ants mainly came from the general public. There is no pub-
lished evidence available for the valuation of the remaining 
ten capability questionnaires (Table 6).
Applied economic evaluations and potential 
methods to incorporate the capability approach
Ten applied evaluations were identified in this review that 
have used a capability-based instrument as secondary out-
come measure in health economic evaluations. No economic 
evaluation was found where a capability instrument was used 
as a primary measure of health outcomes. The information 
extracted from the applied evaluations is presented in 
Table 7 and in Appendix 6.
The number of economic evaluations reporting the use 
of a capability instrument has increased in recent years and 
further increases can be expected given that this search 
identified a number of recent study protocols (e.g. [41, 42, 
114]). Four further studies were identified that specifically 
addressed the issues and discussed considerations when 
incorporating the capability approach into health-related 
economic evaluations.
A recent review [13] focused on using the capability 
approach in health research, not limited to economic evalua-
tions. It identified four distinct common areas of application 
including: (1) physical activity and diet; (2) patient empow-
erment; (3) multidimensional poverty and (4) assessments 
of health and social care interventions. The authors also 
noted that there is a noticeable non-reliance on health status 
as a sole indicator of capability in health, and differences 
were found across studies in approaches to applying mixed 
methods, selecting capability dimensions and weighting 
capabilities. The current review identified applied economic 
evaluations from areas with widely accepted issues related to 
outcomes beyond the QALYs framework, e.g. mental health, 
visual impairment, chronic diseases and health decline in 
older people.
The presentation of results in the included economic eval-
uations demonstrate that there is a lack of consensus regard-
ing the most appropriate way to use capability instruments 
in economic evaluations. Some authors present cost and out-
come data separately and conduct a cost-consequence analy-
sis [42–45], whilst others reported the results following the 
idea behind the incremental cost-effectiveness ratio (ICER) 
[31, 46]. This lack of consensus about the use of capabil-
ity instruments in decision making relates to the different 
approaches taken by different research groups to valuation, 
which means that in practice these measures are not com-
parable along the lines of a QALY. The idea of CALYs has 
been proposed by Mansdotter et al. [47] who highlights the 
following issues. First, it is questionable which capabilities 
are able to explain differences in well-being and are sensitive 
to public policies in high-income countries. Second, ques-
tions of the relevant instruments should capture voluntary 
Table 6  Valuation of capability instruments for health economic evaluations
Instrument Methods of valuation Number of 
choices per BWS 
task
Number of BWS 
tasks per respond-
ents
Population Number of informants References
ASCOT BWS, TTO 4 8 General public 958 (BWS) + 126 (TTO) [52]
ICECAP-A BWS 5 16 General public 413 [85]
ICECAP-O Variants of DCEs and 
BWS tasks (online)
5 16 General public 
aged 65 or over
255 [88]
ICECAP-SCM BWS 7 16 General public 6020 [101, 110]
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and involuntary positions because an applied conceptualiza-
tion of the capability approach includes opportunity as well 
as achievement. Third, methods for weighting capability and 
threshold values should be established, similar to QALYs. 
Finally, a trade-off should be made between the maximisa-
tion of capability and equity.
Mitchell et al. [48] proposed the concept of years of suf-
ficient capability which is more closely aligned to the the-
ory underpinning the capability approach because it has a 
greater focus on those in capability poverty. The process of 
defining a threshold for sufficient capability should be based 
on generating a sufficient capability score and using these 
scores to produce a capability outcome over time [48]. The 
use of ICECAP-A in the economic evaluations included in 
this literature review seem to focus on the choice between 
the options of years of full capability vs. years of sufficient 
capability equivalent [48].
The current state of the art identified in the reported 
economic evaluations applying the capability approach to 
their assessment are in line with the previously identified 
main challenges [50], including the need to research what 
the value of a capability improvement is, how to use the 
instruments globally, and compare the sensitivity of each 
measure to different patient groups and conditions. Only 
one study [49] was identified that posed a critique to using 
the capability approach in health economic evaluations. The 
authors claim that the method used in the questionnaires 
to measure capability will result in a capability set that is 
an inaccurate description of the individual’s true capabil-
ity set. The measured capability set will either represent 
only one combination and ignore the value of choice in 
the capability set, or represent one combination that is not 
actually achievable by the individual. In addition, existing 
methods of valuing capability may be inadequate because 
Table 7  Applied evaluations using the capability approach in their economic evaluations
a Nearly identical means that the difference between baseline and follow-up are within a 10% range when comparing the QALYs and capability 
estimates
Capability 
measure
Disease Time points Other HE 
measures
Changes in QALYs 
vs. capability values
Presentation of results Reference
ICECAP-A Visual impairment Baseline; 
2–4 months
EQ-5D-5L Nearly  identicala Cost per Year of Full 
Capability (YFC)
[111]
Diabetic plantar ulcera-
tion
Baseline; 6 months EQ-5D-5L QALYs negative; 
Capability positive
Cost and outcome data 
presented separately
[43]
Drug addiction Baseline; 12 months EQ-5D-5L Full capability 
higher than Suf-
ficient capability, 
and both higher 
than QALYs
Years of full capability 
(YFC), years of sufficient 
capability equivalent 
(YSC)
[112]
Schizophrenia Baseline; 12–36–
48 weeks
EQ-5D-3L Nearly  identicala Cost and outcome data 
presented separately
[44]
ICECAP-O Health decline in the 
older people
Baseline; 3 months EQ-5D-3L QALYs positive; 
Capability nega-
tive
Incremental net monetary 
benefit (INMB) regres-
sions based on capability 
QALYs
[31]
Heart failure, chronic 
obstructive pulmonary 
disease, or diabetes
Baseline; 12 months EQ-5D-3L Nearly  identicala Willingness to pay for 
100% improvement in 
capability
[113]
Visual impairment 3 months; post-
intervention; 
pre-study
EQ-5D-5L Capability higher 
than QALYs
Costs per years of well-
being
[46]
Hip fracture Baseline; 3 months EQ-5D-3L Capability lower 
than QALYs
Cost and outcome data 
presented separately
[42]
OxCAP-MH Psychosis Baseline; 
6–12 months
EQ-5D-3L Nearly  identicala Cost and outcome data 
presented separately
[45]
ICECAP-A and 
OxCAP-MH
Schizophrenia or schiz-
oaffective disorder and 
depression
Baseline, 
3–6–9 months
EQ-5D-5L QALYs positive; 
Capability: no sig-
nificant change
Cost and outcome data 
presented separately
[114]
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they do not consider that capability is a set. (Although the 
Oxford instruments were developed based on Nussbaum’s 
10 basic human capabilities.) Hence, it may be practically 
more feasible to measure and value capability approximately 
rather than directly. Nevertheless, the argument is based on 
the questionable assumption that all capabilities have to be 
traded against other capabilities.
Discussion
This systematic literature review about capability instru-
ments in economic evaluations of health-related interven-
tions included 98 articles and identified 14 capability-based 
instruments. It provides a unique, comprehensive synthesis 
of the relevant evidence by focusing on the full spectrum of 
potentially available capability measures and summarising 
the practical and theoretical aspects of use of these instru-
ments in economic evaluations. Most identified information 
related to the ASCOT, ICECAP-A, ICECAP-O and OxCAP-
MH instruments.
The development of capability instruments relies on 
methods similar to those applied in the case of HRQoL 
measures. Capability instruments were often compared to 
EQ-5D, but less often to each other. Possible reasons for 
this are that some instruments are population or disease-
specific, and that the inclusion of two instruments meas-
uring the same concept in an applied evaluation study is 
assumed to unnecessarily increase participants’ completion 
burden. In general, the information identified in the litera-
ture regarding the comparison of capability measures with 
other instruments could not be used for a pooled analysis. 
This is mainly due to the vast variation in the correlation 
measures used, the instruments compared, the characteristics 
of the populations and the number of informants. Despite 
the diverse quantitative estimates for the correlations with 
EQ-5D, the different capability instruments and the limited 
available data, this review confirms that capability measures 
capture a wider range of outcomes than the EQ-5D and may 
be more responsive when an intervention is likely to have 
broad impacts on HRQoL. Following the guidelines [51] to 
evaluate the strength of correlations, this generally observed 
moderate-to-high correlation suggests that EQ-5D and capa-
bility instruments measure somewhat similar, yet comple-
mentary concepts. However, there are competing statements 
in the literature regarding the association between capabil-
ity and HRQoL instruments. Most authors argue that these 
measures complement each other; however, some studies 
suggest that capability instruments could be perceived as 
enhancements of the HRQoL concept. It is possible that 
this relationship depends on the choice of both capabil-
ity and health instruments used in these comparisons. For 
instance, the OxCAP-MH has a relatively high number of 
items, which potentially capture a broader range of capabil-
ity concepts than measures such as the ICECAP measures. 
Similarly, the EQ-5D measure of health has a narrower focus 
than other health measures such as measures based on SF-36 
or the AQoL. The higher correlations between capability 
instruments and the EQ-5D-VAS scores than those observed 
between capability instruments and the EQ-5D utility scores 
suggest that respondents’ overall judgement of their health 
status on a VAS seems to reflect better broader quality-of-
life concepts present in the capability approach than specific 
scores for a certain limited number of HRQoL dimensions. 
Moreover, the differences in correlations found between 
measures may be due to differences in the populations stud-
ied. Hence, further research could explore which population 
subgroups and disease areas could benefit from the inclusion 
of certain capability instruments in economic evaluations.
Three of the identified 14 capability instruments were 
used in applied economic evaluation of interventions in the 
health and social care field; however, only as secondary out-
come measures. Eight of the identified ten applied economic 
evaluations were conducted in the United Kingdom. This 
may be the result of the fact that the measures were devel-
oped in the UK and only available in English for some years. 
From the perspective of (health) economists concerned with 
economic evaluations, a good outcome measure should pos-
sess three main characteristics [2]. First, it should be compa-
rable among diseases and interventions to allow for interpre-
tation in a comparative way for resource allocation purposes. 
The capability instruments identified in this literature review 
were developed for specific population groups; hence, a 
comparison is currently challenging without a standard 
application of, for instance, the CALYs framework. Second, 
the instruments should have a scale with interval properties. 
All instruments provide a summary score; however, only 
a few are anchored and therefore have interval properties. 
The ICECAP scores are anchored on no capability and full 
capability, and the ASCOT scales are anchored on death and 
full capability. Finally, most economists are looking for an 
outcome measure for economic evaluation that reflects pref-
erences, either of individual patients or the general public. 
Instruments with tariffs derived from the general population 
(ASCOT, ICECAP-A and ICECAP-SCM) or the relevant 
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subpopulation (ICECAP-O) possess this characteristic. On 
the other hand, reducing capabilities information only to a 
single, preference-based index value on a scale of 0–1 may 
limit the actionable policy relevance of the information [39]. 
The two approaches, however, are not mutually exclusive 
and more research is needed about the relative values of 
different capabilities and their variance according to popula-
tion specifics (e.g. age, disease experience, culture). More 
information about the weights people allocate to the attrib-
utes and levels of capability instruments would be needed to 
improve our understanding of the relative value of individual 
capability domains and dimensions.
Major limitations of this study design include that the 
search was limited to English and German. Next, this review 
only assessed instruments and studies reported in the lit-
erature, and a thorough grey literature search could not be 
conducted due to difficulties with the search term capabil-
ity. In terms of grey literature, only dedicated websites of 
capability instruments were reviewed for relevant informa-
tion. This resulted in some limitations, for instance, some 
cost-effectiveness components of studies that have used 
ASCOT have not been written up as journal articles and 
fell therefore outside the findings of this review [118, 119]. 
Furthermore, ongoing research and developments could not 
be included which could be important in such a dynami-
cally moving area. For example, we found information about 
ongoing economic evaluations [41, 42, 114] with the iden-
tified instruments where results expected to be published 
soon, additional capability instruments might have been used 
in unpublished economic evaluations, or some are currently 
under development. There is a potential need to update this 
literature review in the future to gather information from 
this rapidly growing body of literature about the potential 
development of additional capability measures, the further 
validation of existing ones, the empirical use of capability 
measures in economic evaluations, and the lessons learned 
from these applications.
Conclusion
There has been an increasing interest in the application of 
the capability-based approach in economic evaluations of 
health-related interventions. Different instruments are avail-
able and the choice between them should be based on both 
the research question and the characteristics of the instru-
ments. Further research should focus on the comparison 
of the existing capability instruments and examining the 
correlation across capability measures. This would help 
future researchers in choosing the most suitable capability 
instrument for their study and provide further information 
for instrument developers.
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need to obtain permission directly from the copyright holder. To view a 
copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/
Appendix 1: search strategy
Embase and Medline via Embase.com
((‘economic evaluation’/exp OR ‘economic*’:ti,ab,kw 
OR ‘cost-effective*’:ti,ab,kw OR ‘cost-utility’:ti,ab,kw 
OR ‘cost-benefit’:ti,ab,kw) AND ((‘ascot’:ti,ab,kw OR 
‘icecap’:ti,ab,kw OR ‘oxcap-mh’:ti,ab,kw) OR (capabilit* 
NEXT/2 (perspective OR approach)):ti,ab,kw)) AND 
(2000:py OR 2001:py OR 2002:py OR 2003:py OR 2004:py 
OR 2005:py OR 2006:py OR 2007:py OR 2008:py OR 
2009:py OR 2010:py OR 2011:py OR 2012:py OR 2013:py 
OR 2014:py OR 2015:py OR 2016:py OR 2017:py OR 
2018:py OR 2019:py) (182 results).
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Web of science
TS = (“economic evaluation”) OR TI = (“economic evalu-
ation”) OR TS = (“economic assessment”) OR TI = (“eco-
nomic assessment”) OR TS = (cost-effectiveness) OR TI 
= (cost-effectiveness) OR TS = (cost-utility) OR TI = 
(cost-utility) OR TS = (cost-benefit) OR TI = (cost-benefit) 
AND TS = (“capabilit* approach”) OR TI = (“capabilit* 
approach”) OR TS = (“capabilit* perspective”) OR TI = 
(“capabilit* perspective”) OR TS = (ascot) OR TI = (ascot) 
OR TS = (icecap*) OR TI = (icecap*) OR TS = (oxcap-mh) 
OR TI = (oxcap-mh)
Limitations: Last 20 years
Indexes = SCI-EXPANDED, SSCI, A&HCI, CPCI-S, 
CPCI-SSH, ESCI (90 results)
Psychinfo
((capabilit* or ascot or oxcap-mh or icecap).ab. or (capa-
bilit* or ascot or oxcap-mh or icecap).ti.) and ((cost-effec-
tiveness or cost-utility or cost-benefit or economic evalu-
ation or economic assessment).ti. or (cost-effectiveness or 
cost-utility or cost-benefit or economic evaluation or eco-
nomic assessment).ab.)
Limitations: Last 20 years (82 results)
Scopus
TITLE-ABS-KEY ((“capabilit* approach”) OR (“capabilit* 
perspective”) OR (ascot) OR (oxcap-mh) OR (icecap)) AND 
TITLE-ABS-KEY ((economic AND evaluation) OR (eco-
nomic AND assessment) OR cost-effectiveness OR cost-
utility OR cost-benefit)
Limitations: English, German, last 20 years (174 results)
Appendix 2: data extraction
The final list of extracted data in case of applied papers 
included 
• First author,
• Year of publication (1999, …, 2018),
• Country of study, Disease area,
• Type of intervention,
• Population under investigation,
• Aim of study (to assess cost-effectiveness, to …),
• Type of economic evaluation (cost-minimisation analy-
sis, cost-consequence analysis, cost-effectiveness analy-
sis, cost-utility analysis, cost–benefit analysis, not appli-
cable),
• Perspective of study (healthcare service, societal, other),
• Capability instrument used (multiple choice between: 
ICECAP-A, ICECAP-O, OxCAP-MH, ASCOT, Other),
• Time points of measurement (pre-study, baseline, post-
study, 1 month, …, 12 months, beyond 12 months),
• Other instruments used,
• Methods to address missing data,
• Presentation of results, e.g. cost/CALYs, p value of 
capability instrument (less than 0.05, greater than 0.05), 
Comparison of results to QALYs (lower, nearly identical, 
higher),
• Comparison of incremental cost-effectiveness ratios 
(difference in costs per extra year to gain well-being, 
expressed in EUR),
• Use of capability data in economic modelling (yes, no),
• Recommendation to apply capability in future economic 
evaluations (yes, no),
• Further comments on the capability instrument.
Data extraction in case of methods papers included the 
• First author,
• Year of publication (2009, …, 2018),
• Type of study (Comparison of questionnaires; Develop-
ment of questionnaires; Methods to incorporate CA to 
economic evaluation; Theoretical background of CA),
• Aim of study,
• Capability instrument in question (multiple choice 
between: ICECAP-A, ICECAP-O, OxCAP-MH, ASCOT, 
Other),
• Recommendation to apply capability in future economic 
evaluations (yes, no),
• Further comments on the capability instrument.
Appendix 3
See Table 8.
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Table 8  List of included papers Author Year References Category Instrument(s)
Al-Janabi 2012 [53] Development ICECAP-A
Al-Janabi 2015 [77] Validation ICECAP-A
Al-Janabi 2013 [33] Validation ICECAP-A
Al-Janabi 2013 [82] Validation ICECAP-A
Bailey 2016 [29] Validation ICECAP-SCM
Barnes 2016 [44] Empirical ICECAP-A
Baumgardt 2018 [103] Validation OxCAP-MH
Botes 2018 [60] Development CAF
Botes 2018 [115] Validation CAF
Bray 2017 [111] Empirical ICECAP-A
Burns 2016 [45] Empirical OxCAP-MH
Chen 2018 [20] Validation ICECAP-A
Coast 2008 [88] Valuation ICECAP-O
Coast 2016 [100] Valuation ICECAP-SCM
Coast 2008 [40] Validation ICECAP-O
Coast 2018 [83] Validation ICECAP-A, ICECAP-SCM
Comans 2012 [97] Validation ICECAP-O
Couzner 2012 [22] Comparison ICECAP-O
Couzner 2013 [36] Validation ICECAP-O
Davis 2013 [25] Comparison ICECAP-O
Davis 2016 [30] Validation ICECAP-O
Davis 2017 [35] Validation ICECAP-O
Engel 2018 [78] Validation ICECAP-A
Engel 2018 [79] Validation ICECAP-A
Engel 2016 [89] Validation ICECAP-O
Engel 2017 [24] Comparison ICECAP-A
Flynn 2015 [85] Valuation ICECAP-A
Forder 2011 [68] Validation ASCOT
Franklin 2018 [26] Comparison ICECAP-O
Goranitis 2016 [34] Comparison ICECAP-A
Goranitis 2017 [112] Empirical ICECAP-A
Goranitis 2016 [23] Validation ICECAP-A
Greco 2018 [102] Validation low-income Q
Greco 2015 [64] Development low-income Q
Grewal 2006 [54] Development ICECAP-O
Hackert 2017 [21] Comparison ASCOT, ICECAP-O
Hackert 2019 [90] Validation ICECAP-O
Handels 2018 [109] Translation ICECAP-O
Henderson 2013 [113] Empirical ICECAP-O
Horder 2016 [86] Validation ICECAP-O
Horwood 2014 [91] Validation ICECAP-O
Huynh 2017 [101] Valuation ICECAP-SCM
Jones 2017 [32] Validation ICECAP-A
Kaambwa 2019 [69] Validation ASCOT
Karimi 2016 [49] Incorporation General
Keeley 2013 [80] Validation ICECAP-A
Keeley 2015 [81] Validation ICECAP-A
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Table 8  (continued) Author Year References Category Instrument(s)
Keeley 2016 [27] Comparison ICECAP-A
Khan 2018 [116] Validation ICECAP-A
Kinghorn 2015 [65] Development Pain Q
Łaszewska 2019 [17] Comparison OxCAP-MH
Linton 2018 [108] Validation ICECAP-A
Looman 2014 [98] Validation ICECAP-O
Lorgelly 2015 [63] Development OCAP-18
Makai 2014 [6] Validation ASCOT, ICECAP-O
Makai 2015 [31] Empirical ICECAP-O
Makai 2012 [92] Validation ICECAP-O
Makai 2014 [18] Validation ICECAP-O
Malley 2012 [70] Validation ASCOT
Mansdotter 2017 [47] Incorporation General
Milte 2014 [71] Comparison ASCOT
Milte 2018 [93] Validation ICECAP-O
Mitchell 2017 [13] Incorporation General
Mitchell 2015 [37] Validation ICECAP-A
Mitchell 2013 [94] Comparison ICECAP-O
Mitchell 2015 [48] Incorporation General
Mitchell 2017 [38] Comparison ICECAP-A
Netten 2012 [52] Development ASCOT
Parker 2019 [43] Empirical ICECAP-A
Parsons 2014 [95] Validation ICECAP-O
Patty 2018 [46] Empirical ICECAP-O
Peak 2018 [84] Validation ICECAP-A
Rand 2017 [72] Comparison ASCOT
Rand 2012 [58] Development ASCOT-proxy
Ratcliffe 2013 [99] Validation ICECAP-O
Sacchetto 2016 [56] Development ACQ‐CMH‐104
Sacchetto 2018 [66] Validation ACQ‐CMH‐104
Sarabia-Cobo 2017 [87] Comparison ICECAP-O
Shiroiwa 2018 [105] Validation ASCOT
Simon Unpublished [114] Empirical OxCAP-MH
Simon 2018 [117] Translation OxCAP-MH
Simon 2013 [39] Development OxCAP-MH
Stevens 2018 [73] Comparison ASCOT
Sutton 2014 [62] Development ICECAP-SCM
Tang 2018 [107] Comparison ICECAP-A
Towers 2015 [75] Validation ASCOT
Towers 2016 [67] Validation ASCOT
Turnpenny 2018 [57] Development ASCOT Easy Read
Van Leeuwen 2015 [74] Comparison ASCOT, ICECAP-O
Van Leeuwen 2015 [106] Validation ASCOT
Van Leeuwen 2014 [104] Validation ASCOT
Van Leeuwen 2015 [28] Validation ASCOT, ICECAP-O
Vergunst 2017 [19] Comparison OxCAP-MH
Williams 2016 [42] Empirical ICECAP-O
Xin 2017 [96] Comparison ICECAP-O
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Appendix 5
See Table 10.
Table 10  Abbreviations of 
health-related instruments Short form Full name of instrument
15D 15D
SF-36 36-Item Short Form Health Survey
ADRQL Alzheimer’s Disease-Related Quality of Life
AQoL-8D Assessment of Quality-of-Life Multi-Attribute Utility Instrument
Barthel Index Barthel Index measure of activities of daily living (ADL)
OPQOL-brief brief Older People’s Quality of Life
BPRS Brief Psychiatric Rating Scale
BSI-18 brief symptom inventory 18
Cantril’s Ladder Cantril’s Ladder
CES Carer Experience Scale
CSI Carer Strain Index
CASP-12 Control and autonomy subscale of CASP-12
CTM-3 Care Transitions Measure
DASS-D Depression, Anxiety and Stress Scale (DASS-D of DASS-21)
EQ-5D + C EQ-5D extended with a cognitive dimension
EQ-5D-VAS EuroQol Visual Analogue Scale
GDS-15 15-item Geriatric Depression Scale
GHQ-12 12-item General Health Questionnaire
GAF Global Assessment of Functioning
HUI-3 Health Utilities Index Mark 3
K10 Kessler Psychological Distress Scale
LDQ Leeds Dependence Questionnaire
Mini-ICF-APP Mini-ICF-APP Social Functioning Scale
SIX Objective Social Outcomes Index
OPQoL-Brief Older People’s Quality-of-Life brief questionnaire (13 items)
OHS Oxford Hip Score
PDQ-39 Parkinson’s specific Quality of Life
RAS-P Recovery Assessment Scale
SF-6D Short Form Six Dimension
SSQ Social Satisfaction Questionnaire
SWLS Satisfaction with Life Scale
WOMAC Western Ontario and McMaster Universities
WHOQOL-Bref World Health Organization Quality-of-Life Instruments - abbreviated version
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